IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease

Clinical and Experimental Immunology

Volumn 115, Issue 2, 1999, Pages 236-247

  Skyllouriotis, P ^a   Skyllouriotis Lazarou, M ^a   Natter, S ^a   Steiner, R ^a   Spitzauer, S ^a   Kapiotis, S ^a   Valent, P ^b   Hirschl, A M ^a   Guber, S E ^a   Laufer, G ^a   Wollenek, G ^a   Wolner, E ^a   Wimmer, M ^a   Valenta, Rudolf ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoantibody; Cardiac myosin; Cardiomyopathy; Th1 autoimmunity

Indexed keywords

HEART ANTIBODY; IMMUNOGLOBULIN G; MYOSIN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032926660     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00807.x     Document Type: Article

References (55)

1. 1 Hein S, Schaper J. Pathogenesis of dilated cardiomyopathy and heart failure: insights from cell morphology and biology. Curr Opin Cardiol 1996; 11:293-301.
2. 2 Kuhn H, Gietzen F, Beer G, Pethig K. Epidemiology of idiopathic dilated cardiomyopathy. In: Figulla HR, Kandolf R, McManus B, ed. Idiopathic dilated cardiomyopathy: cellular and molecular mechanisms, clinical consequences Berlin: Springer-Verlag, 1993:13-25.
3. 3 Durand JB, Bachinski LL, Bieling LC et al. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 1995; 92:3387-9.
4. 4 Tanigawa G, Jarcho JA, Kass S et al. A molecular basis for familial hypertrophic cardiomyopathy: an α/β cardiac myosin heavy chain hybrid gene. Cell 1990; 62:991-8.
5. 5 Geisterfer-Lowrance AAT, Kass S, Tanigawa G et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 1990; 62:999-1006.
6. 6 Sata M, Ikebe M. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J Clin Invest 1996; 98:2866-73.
7. 7 Pieske B, Kretschmann B, Meyer M et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995; 92:1169-78.
8. 8 Böhm M, Lohse MJ. Quantification of β-adrenoreceptors and β-adrenoreceptor kinase on protein and mRNA levels in heart failure. Eur Heart J 1994; 15:30-34.
9. 9 Herskowitz A, Neumann DA, Ansari AA. Concepts of autoimmunity applied to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993; 22:1385-8.
10. 10 Caforio ALP, Keeling PJ, Zachara E et al. Evidence from familial studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344:773-7.
11. 11 Magnusson Y, Mallukat G, Waagstein F et al. Autoimmunity in idiopathic dilated cardiomyopathy. Circulation 1994; 89:2760-7.
12. 12 Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J (Suppl) 1994; 72:30-34.
13. 13 Goldman JH, McKenna WJ. Immunopathogenesis of dilated cardiomyopathies. Curr Opin Cardiol 1995; 10:306-11.
14. 14 Caforio ALP, Goldman JH, Haven AJ et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996; 54:157-63.
15. 15 Penninger JM, Neu N, Bachmaier K. A Genetic map of autoimmune heart disease. The Immunologist 1996; 4/4:131-41.
16. 16 Penninger JM, Pummerer C, Liu P et al. Cellular and molecular mechanisms of murine autoimmune myocarditis. APMIS 1997; 105: 1-13.
17. 17 O'Donoghue HL, Lawson CM, Reed WD. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunology 1990; 71:20-28.
18. 18 Neumann DA, Rose NR, Ansari AA et al. Induction of multiple heart autoantibodies in mice with coxsackievirus B3-and cardiac myosin-induced autoimmune myocarditis. J Immunol 1994; 152:343-50.
19. 19 Penninger JM, Neu N, Timms E. et al. Induction of experimental autoimmune myocarditis in mice lacking CD3 or CD8 molecules. J Exp Med 1993; 178:1837-42.
20. k on antigen-presenting cells in the heart. J Exp Med 1995; 182:1291-300.
21. 21 Kasahara H, Itoh M, Sugiyama T et al. Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest 1994; 94:1026-36.
22. 22 Huber SA, Polgar J, Schultheiss P et al. Augmentation of pathogenesis of Coxsackievirus B3 infections in mice by exogenous administration interleukin-1 and interleukin-2. J Virol 1994; 68:195-206.
23. 23 Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994; 89:846-51.
24. 24 Rose NR, Hill SL. Autoimmune myocarditis. Im J Cardiol 1996; 54:171-5.
25. 25 Caforio ALP, Grazzini M, Mann JM et al. Identification of α-and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85:1734-42.
26. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86:1658-63.
27. 27 Fu LX, Magnusson Y, Bergh CH et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91:1964-8.
28. 28 Schulze K, Beeker BF, Schauer R et al. Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy impair cardiac function. Circulation 1990; 81:959-69.
29. 29 Latif N, Baker CS, Dunn MJ et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993; 22: 1378-84.
30. 30 Maisch B. Anticardiac antibodies in hypertrophic cardiomyopathy as a marker of severity. Postgrad Med J 1992; 68 (Suppl. 1) 1:29-35.
31. 31 Matsumori A, Yamada T, Suzuki H et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72:561-6.
32. 32 Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 1996; 11:302-9.
33. 33 Limas CJ, Goldenberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 1995; 91:631-4.
34. 34 Dörffel WV, Felix SB, Wallukat G et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95:1994-7.
35. 35 Wallukat G, Reinke P, Dörffel WV et al. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996; 54:191-5.
36. 36 Brandenburg RO, Chazov E, Cherian G et al. Report of the WHO/ISFC task force on definition and classification of cardiomyopathies. Circulation 1981; 64:437A-438A.
37. 37 Jaffe EA, Nachman RL, Becker CG et al. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52:2745-51.
38. 38 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
39. 39 Fling SP, Gregerson DS. Peptide and protein molecular weight determination by electrophoresis using a high molarity Tris buffer system without urea. Anal Biochem 1986; 155:83-88.
40. 40 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
41. 41 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels lo nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
42. 42 Cunningham MW, Antone SM, Gulizia JM et al. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci USA 1992; 89:1320-4.
43. 43 Kil KS, Cunningham MW, Barnett LA. Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens. Infect Immun 1994; 62:2440-9.
44. 44 Keeling PJ, Tracy S. Link between enteroviruses and dilated cardiomyopathy: serological and molecular data. Br Heart J 1994; 72 (Suppl.):25-29.
45. 3 antibody subclasses in vivo. Eur J Immunol 1995; 25:823-9.
46. 46 Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis: heart autoantibodies are not involved in the induction of the disease. J Immunol 1990; 145:4094-100.
47. 47 Bromelow KV, Souberbielle B, Alavi A et al. Lack of T cell response to cardiac rnyosin and a reduced response to PPD in patients with idiopathic dilated cardiomyopathy. J Autoimmun 1997; 10:219-27.
48. 48 McNamara DM, Rosenblum WD, Janosko KM et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997; 95:2476-8.
49. 49 Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantihodies into living cells. Immunol Today 1996; 17:163-4.
50. 50 Yanase K, Smith RM, Jarett L et al. Receptor-mediated cellular entry of nuclear anti-DNA antibodies via myosin 1. J Clin Invest 1997; 100:25-31.
51. 51 Margossian SS, Krueger JW. Sellers JR et al. Influence of the cardiac myosin hinge region on contractile activity. Proc Natl Acad Sci USA 1991; 88:4941-5.
52. 52 Charlton B, Lafferty KJ. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995; 7:793-8.
53. 53 Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Autoimmunity 1996; 8:837-42.
54. 54 Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-6.
55. 55 Adorini L, Sinigaglia F. Pathogenesis and immunotherapy of autoimmune diseases. Immunol Today 1997; 18:209-11.